Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 55 citing articles:

Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial
Shaun Sabico, Mushira A. Enani, Eman Sheshah, et al.
Nutrients (2021) Vol. 13, Iss. 7, pp. 2170-2170
Open Access | Times Cited: 175
Curcumin as a Potential Treatment for COVID-19
Bruna Rattis, Simone G. Ramos, Mara Rúbia Nunes Celes
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 126
Recent advances in management of COVID-19: A review
Soraya Mouffak, Qamar Shubbar, Ekram Saleh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112107-112107
Open Access | Times Cited: 76
Ultrastructural insight into SARS-CoV-2 entry and budding in human airway epithelium
Andreia Pinto, Ranjit Rai, Jonathan C. Brown, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
Alex J.B. Kreutzberger, Anwesha Sanyal, Ravi Ojha, et al.
Journal of Virology (2021) Vol. 95, Iss. 21
Open Access | Times Cited: 40
Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract
Manel Essaidi-Laziosi, Catia Alvarez, Olha Puhach, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 413-424
Open Access | Times Cited: 40
Insight into the role of clathrin‐mediated endocytosis inhibitors in SARS‐CoV‐2 infection
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Soumya Ghosh, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 29
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 15
Generation of RNA aptamers against chikungunya virus E2 envelope protein
Kaku Goto, R. S. Amano, Ichinose Akiko, et al.
Journal of Virology (2025)
Closed Access
Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection: a multi-centre case–control study
Nasser M. Al‐Daghri, Osama E. Amer, Naif H. Alotaibi, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 33
Vitamin D deficiency and COVID-19: A case-control study at a tertiary care hospital in India
Nirav Nimavat, Shruti Singh, Pratibha Singh, et al.
Annals of Medicine and Surgery (2021) Vol. 68
Open Access | Times Cited: 32
An overview of the role of Niemann-pick C1 (NPC1) in viral infections and inhibition of viral infections through NPC1 inhibitor
Ahmad Irfan, Seyede Narges Fatemi, Mohammad Ghaheri, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry
Olga V. Matveeva, Yury D. Nechipurenko, Denis Lagutkin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Nanovaccines against Viral Infectious Diseases
Wen Tzuen Heng, Jia Sheng Yew, Chit Laa Poh
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2554-2554
Open Access | Times Cited: 20
Mechanistic-Based Classification of Endocytosis-Related Inhibitors: Does It Aid in Assigning Drugs against SARS-CoV-2?
Mohamed Hessien, Thoria Donia, Ashraf A. Tabll, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1040-1040
Open Access | Times Cited: 10
Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis
Nabab Khan, Jonathan D. Geiger
Viruses (2021) Vol. 13, Iss. 8, pp. 1466-1466
Open Access | Times Cited: 22
Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function
María A. Oliva, Carlota Tosat‐Bitrián, Lucía Barrado-Gil, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3448-3448
Open Access | Times Cited: 14
Bromodomains in Human-Immunodeficiency Virus-Associated Neurocognitive Disorders: A Model of Ferroptosis-Induced Neurodegeneration
Adonis Sfera, Karina G. Thomas, Christina V. Andronescu, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 14
Possible Therapeutic Use of Natural Compounds Against COVID-19.
Nabab Khan, Xuesong Chen, Jonathan D. Geiger
PubMed (2021) Vol. 2, Iss. 1, pp. 63-79
Closed Access | Times Cited: 18
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.
Damian Balmforth, James A Swales, Laurence Silpa, et al.
Journal of Clinical Virology (2022) Vol. 155, pp. 105248-105248
Open Access | Times Cited: 13
Role of different types of RNA molecules in the severity prediction of SARS-CoV-2 patients
Pratheeba Jeyananthan
Pathology - Research and Practice (2023) Vol. 242, pp. 154311-154311
Open Access | Times Cited: 7
Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants
Oleg O. Glebov
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Unveiling the Effect of Low pH on the SARS-CoV-2 Main Protease by Molecular Dynamics Simulations
Haruna Luz Barazorda-Ccahuana, Miroslava Nedyalkova, Francesc Mas, et al.
Polymers (2021) Vol. 13, Iss. 21, pp. 3823-3823
Open Access | Times Cited: 13
Therapeutic potential of natural alkaloid emetine against emerging COVID-19 and future viral pandemics
Biswanath Dinda, Subhajit Dinda, Manikarna Dinda, et al.
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100173-100173
Open Access | Times Cited: 1
Metallomic analysis of urine from individuals with and without Covid-19 infection reveals extensive alterations in metal homeostasis
Ketolly Natanne da Silva Leal, Ana Beatriz Silva, Elisânia Kelly Barbosa Fonseca, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 86, pp. 127557-127557
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top